期刊文献+

miR-34a抑制SW480细胞增殖的机制研究 被引量:3

MIR-34A INHIBITORY EFFECTS ON SW480 CELL PROLIFERATION
下载PDF
导出
摘要 目的探索miR-34a的生物学功能及其对肠癌细胞的抑制作用。方法通过检索miRTar Base和miRBase数据库,筛选出已经实验验证的miR-34a靶基因,使用Cytoscape软件对筛选出的靶基因进行功能富集分类,构建靶基因相互作用网络,用DAVID数据库对miR-34a的靶基因进行信号通路富集分析;免疫印迹技术检测miR-34a对SIRT1、NOTCH1蛋白表达的影响;MTT法检测转染miR-34a对SW480细胞增殖的影响。结果共有56个基因被确定为miR-34a的靶基因,对靶基因进行功能富集分析包含Wnt Signaling Pathway and Pluripotency、Pathways in cancer、MicroRNAs in cancer、Notch signaling pathway等;对靶基因进行信号通路富集分析(p<0.001;FDR<0.05),共富集到8条通路,包含Pathways in cancer、Small cell lung cancer、Colorectal cancer等。免疫印迹结果显示SW480细胞转染miR-34a类似物后,SIRT1、NOTCH1蛋白的表达水平较对照组明显下降(p<0.01);SW480细胞转染miR-34a类似物后生长速度明显减慢,培养5天后检测两组有显著统计学差异(p<0.05)。结论 miR-34a靶基因参与多个信号通路;miR-34a可能通过负性靶向调控SIRT1、NOTCH1基因的表达而抑制SW480细胞的增殖。 Objective To analyze the biological function and the effect of miR -34a on SW480 cell proliferation.Methods Target genes of miR-34a were filtrated by TarBase and miRBase, and the intersection of the target genes was performed by Cyto-scape; Pathway analysis was performed by DAVID.The expression level of SIRT1,NOTCH1 protein affected by miR-34a were de-tected by Western blotting.The proliferation of SW480 cells was measured by MTT assay.Results 56 verified target genes of miR-34a were filtrated, which were enriched in Wnt Signaling Pathway and Pluripotency, Pathways in cancer, MicroRNAs in cancer, Notch signaling pathway et al;Pathway analysis showed the genes set mainly mapped in 8 pathways (p〈0.001;FDR〈0.05), inclu-ding pathways in cancer, small cell lung cancer, colorectal cancer, et al.Western blotting results demonstrated that the SIRT1 and NOTCH1 protein level in the SW480 cells transfected with miR-34a mimics decreased compared with the negative control group (p〈0.01);The growth of SW480 cells transfected with miR-34a mimics was much slower than negative control group (p〈0.01). Conclusion miR-34a may be involved in the different signaling pathways and inhibit SW480 cell proliferation by downloading the expression of SIRT1 and NOTCH1.
出处 《现代医院》 2015年第8期7-9,共3页 Modern Hospitals
基金 国家自然科学基金(编号:81201662)
关键词 MIR-34A 生物信息学 SIRT1 NOTCH1 细胞增殖 miR-34a miR-34a bioinformatics cell proliferation
  • 相关文献

参考文献18

  • 1JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin,2008,58(2) :71 -96.
  • 2陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:883
  • 3KANG L, MAO J, TAO Y, et al. MiR -34a Suppresses the Breast Cancer Stem Cell - like Characteristics by Downregulating Notch1 Pathway [ J]. Cancer Sci ,2015,106 ( 6 ) :700 - 708.
  • 4LAI M, DU G, SHI R, et al. miR -34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells [ J ]. Mol Med Rep,2015, 11 ( 5 ) : 3301 - 3307.
  • 5杨群芳,严伟玲.卵巢恶性肿瘤组织中微小RNA的检测及其临床意义[J].现代医院,2014,14(7):72-75. 被引量:2
  • 6WANG R, MA J, WU Q, et al. Functional role of miR -34 fami- ly in human cancer [ J ]. Curr Drug Targets,2013,14 ( 10 ) : 1185 -1191.
  • 7YAMAKUCHI M, LOWENSTEIN C J. MiR- 34, SIRT1 and p53: the feedback loop[Jl. Cell Cycle,2009,8(5) :712 -715.
  • 8BRABLETZ T. MiR - 34 and SNAIL : another double - negative feedback loop controlling cellular plasticity/EMT governed by p53 [J]. Cell Cycle,2012,11(2) :215 -216.
  • 9HERMEKING H. The miR - 34 family in cancer and apoptosis [J]. Cell Death Differ,2010,17(2) :193 -199.
  • 10DI MARTINO M T, LEONE E, AMODIO N, et al. Synthetic miR -34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence [ J]. Clin Cancer Res, 2012, 18 ( 22 ) :6260 - 6270.

二级参考文献2

共引文献883

同被引文献31

  • 1Siddavaram Nagini.Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention[J].World Journal of Gastrointestinal Oncology,2012,4(7):156-169. 被引量:91
  • 2司文秀,杨继章.非甾体类抗炎药的抗癌作用及机制[J].中国药房,2007,18(19):1510-1512. 被引量:4
  • 3TAKAYAMA T, NAGASHIMA H, MAEDA M, et al. Random- ized double blind trial of sulindac and etodolac to eradicate aber- rant crypt foci and to prevent sporadic colorectal polyps[ J]. Clin Cancer Res,2011,17 : 3803 - 3811.
  • 4SHARMA P, KAUR J, SANYAL S N. Effect of etoricoxib, a cy- clooxygenase -2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model[ J]. Nutr Hosp,2010,25( 1 ) :39 -48.
  • 5MASUNAGA R, KOHNO H, DHAR D K, et al. Enhanced apop- tosis and transforming growth factor - betal expression in colorectal adenomas and carcinomas after Sulindac therapy [ J ]. Dis Colon Rectum,2001,44(7 ) : 1008 - 1015.
  • 6BABBAR N, IGNATENKO N A, CASERO JR R A, et al. Cy- clooxygenase - independent induction of apoptosis by sulindac sul- lone is mediated by polyamines in colon cancer[ J]. J Biol Chem, 2003,278 (48) :47762 - 47775.
  • 7AKASHI I-I, HAN H J, IIZAKA M, et al. Growth - suppressive effect of non - steroidal anti - inflammatory drugs on 11 colon - cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac I J ]- lnt J Cancer, 2000,88 (6) :873 - 880.
  • 8TINSLEY H N, GARY B D, KEETON A B, et al. Sulindac sul- fide selectively inhibits growth and induces apoptosis of human breast tumor ceils by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G [ J ]. Mo| Cancer Ther,2009,$ ( 12 ) : 3331 - 3340.
  • 9ITANO O, YANG K, FAN K, et al. Sulindac effects on inflam- mation and tumorigenesis in the intestine of mice with Apc and Mlhl mutations. Carcinogenesis [ J ]. 2009, 30 ( l I ) : 1923 - ! 926.
  • 10KELLER J J, OFFERHAUS G J, POLAK M, et al. Rectal epi- thelial apoptosis in familial adenomatous polyposis patients treated with sulindac[J~. Gut,1999,45(6) :822 -828.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部